{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:08:46Z","timestamp":1790910526249,"version":"4.1.0"},"reference-count":126,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,11,15]],"date-time":"2006-11-15T00:00:00Z","timestamp":1163548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p>After the global eradication of wild polioviruses, the risk of paralytic poliomyelitis from polioviruses will still exist and require active management. Possible reintroductions of poliovirus that can spread rapidly in unprotected populations present challenges to policymakers. For example, at least one outbreak will likely occur due to circulation of a neurovirulent vaccine\u2010derived poliovirus after discontinuation of oral poliovirus vaccine and also could possibly result from the escape of poliovirus from a laboratory or vaccine production facility or from an intentional act. In addition, continued vaccination with oral poliovirus vaccines would result in the continued occurrence of vaccine\u2010associated paralytic poliomyelitis. The likelihood and impacts of reintroductions in the form of poliomyelitis outbreaks depend on the policy decisions and on the size and characteristics of the vulnerable population, which change over time. A plan for managing these risks must begin with an attempt to characterize and quantify them as a function of time. This article attempts to comprehensively characterize the risks, synthesize the existing data available for modeling them, and present quantitative risk estimates that can provide a starting point for informing policy decisions.<\/jats:p>","DOI":"10.1111\/j.1539-6924.2006.00827.x","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T03:19:28Z","timestamp":1163647168000},"page":"1471-1505","source":"Crossref","is-referenced-by-count":147,"title":["Risks of Paralytic Disease Due to Wild or Vaccine\u2010Derived Poliovirus After Eradication"],"prefix":"10.1111","volume":"26","author":[{"given":"Radboud J. Duintjer","family":"Tebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olen M.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Cochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bruce","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,11,15]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"651","volume-title":"Vaccines","author":"Sutter R. W.","year":"2004"},{"key":"e_1_2_9_3_2","unstructured":"World Health Organization. (2005).Global Polio Eradication Initiative. Available athttp:\/\/www.polioeradication.org\/ accessed September 26 2005."},{"key":"e_1_2_9_4_2","unstructured":"World Health Organization. (2004).Global Polio Eradication Initiative: Progress 2003. Report No.: WHO\/Polio\/04.01 Geneva ."},{"issue":"4","key":"e_1_2_9_5_2","first-page":"35","article-title":"Policy decision options during the first 5 years following certification of polio eradication","volume":"5","author":"Sangrujee N.","year":"2003","journal-title":"Medscape General Medicine"},{"key":"e_1_2_9_6_2","unstructured":"World Health Organization. (1998).Report of the Meeting on the Scientific Basis for Stopping Polio Immunization. Report No.: WHO\/EPI\/GEN\/98.12 Geneva : World Health Organization ."},{"issue":"3","key":"e_1_2_9_7_2","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: Issues and challenges","volume":"78","author":"Wood D. J.","year":"2000","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/338262"},{"key":"e_1_2_9_9_2","first-page":"69","article-title":"The scientific basis for stopping polio immunisation\u2014Issues and challenges","volume":"105","author":"Wood D. J.","year":"2001","journal-title":"Developments in Biologicals"},{"key":"e_1_2_9_10_2","first-page":"153","article-title":"Possible global strategies for stopping polio vaccination and how they could be harmonized","volume":"105","author":"Cochi S. L.","year":"2001","journal-title":"Developments in Biologicals"},{"key":"e_1_2_9_11_2","unstructured":"World Health Organization. (2003).Final report of the WHO informal consultation on identification and management of vaccine\u2010derived polioviruses. Geneva September 3\u20135."},{"key":"e_1_2_9_12_2","unstructured":"World Health Organization. (2004).Global Polio Eradication Initiative: Strategic Plan 2004\u20132008. Geneva ."},{"issue":"45","key":"e_1_2_9_13_2","first-page":"401","article-title":"Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21\u201322 September 2004","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Weekly Epidemiological Record"},{"issue":"1","key":"e_1_2_9_14_2","first-page":"40","article-title":"Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission","volume":"82","author":"Aylward R. B.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_15_2","first-page":"129","article-title":"Stopping a polio outbreak in the post\u2010eradication era","volume":"105","author":"Fine P. E. M.","year":"2001","journal-title":"Developments in Biologicals"},{"key":"e_1_2_9_16_2","first-page":"35","article-title":"Global eradication of poliomyelitis: Benefit\u2010cost analysis","volume":"74","author":"Bart K.","year":"1996","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00584-4"},{"issue":"6","key":"e_1_2_9_18_2","article-title":"The costs of polio risk management policies after eradication","volume":"26","author":"Duintjer Tebbens R. J.","year":"2006","journal-title":"Risk Analysis"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi206"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.58.030603.123625"},{"key":"e_1_2_9_21_2","doi-asserted-by":"crossref","unstructured":"World Bank. (2002).World Bank List of Economies (July 2002). Available athttp:\/\/www.worldbank.org\/data\/databytopic\/CLASS.XLS accessed December 2002.","DOI":"10.1596\/0-8213-5087-0"},{"key":"e_1_2_9_22_2","unstructured":"UNICEF. (2003).The State of the World's Children 2003. Available athttp:\/\/www.unicef.org\/sowc03\/tables\/index.html accessed July 31 2003."},{"key":"e_1_2_9_23_2","volume-title":"Introduction to Probability Models","author":"Ross S. M.","year":"1997"},{"key":"e_1_2_9_24_2","volume-title":"Personal communication: VAPP breakdown and case\u2010by\u2010case characteristics","author":"Alexander L. N.","year":"2004"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.14.1696"},{"key":"e_1_2_9_26_2","unstructured":"Centers for Disease Control and Prevention. (2000).Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices.Morbidity and Mortality Weekly Report 49(RR\u20105) 1\u201322."},{"issue":"10","key":"e_1_2_9_27_2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1987.03390100073029","article-title":"Vaccine\u2010associated paralytic poliomyelitis. United States: 1973 through 1984","volume":"267","author":"Nkowane B. M.","year":"1987","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.568"},{"key":"e_1_2_9_29_2","first-page":"426","article-title":"Vaccine\u2010associated paralytic poliomyelitis among immunodeficient persons","volume":"11","author":"Sutter R. W.","year":"1994","journal-title":"Infections in Medicine"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1994.02170050037007"},{"key":"e_1_2_9_31_2","volume-title":"OPV Immunization and Poliovirus Antibody Prevalence Levels","author":"Brink E. W.","year":"1985"},{"key":"e_1_2_9_32_2","unstructured":"Centers for Disease Control and Prevention. (2002).Live births birth rates and fertility rates by race: United States specified years 1940\u201355 and each year 1960\u20132000.National Vital Statistics Report 50(5) 27."},{"issue":"21","key":"e_1_2_9_33_2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jama.1996.03530450029028","article-title":"Seroprevalence of antibody against poliovirus in inner\u2010city preschool children","volume":"275","author":"Chen R. T.","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(01)00286-0"},{"key":"e_1_2_9_35_2","unstructured":"Smith P. Z.(2001).Personal communication: Data from: US Census Bureau US immunization survey national health interview survey national immunization survey and national immunization program. Atlanta : Assessment Branch Centers for Disease Control and Prevention ."},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.271.11.833"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/6.Supplement_2.S413"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/321905"},{"key":"e_1_2_9_39_2","unstructured":"World Health Organization. (2005).Poliovirus surveillance report January\u2013September 2005.Polio LabNetwork Quarterly Update 11(4) 3\u20134."},{"key":"e_1_2_9_40_2","unstructured":"Centers for Disease Control and Prevention. (2004).Laboratory surveillance for wild and vaccine\u2010derived polioviruses January 2003\u2013June 2004.Morbidity and Mortality Weekly Report 53(42) 990\u2013993."},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0907.020692"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13512-13521.2004"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8366-8377.2003"},{"key":"e_1_2_9_45_2","unstructured":"Centers for Disease Control and Prevention. (2003).Laboratory surveillance for wild and vaccine\u2010derived polioviruses January 2002\u2013June 2003.Morbidity and Mortality Weekly Report 52(38) 913\u2013916."},{"key":"e_1_2_9_46_2","unstructured":"Park R. E. Yang C\u2010F Yang S.\u2010J Campagnoli R. P. Asghar H. Nategh R. &Kew O. M.(2002).Molecular characterization of divergent Sabin 2\u2010derived isolates from patients with paralysis. Presented at the 21st Annual Meeting of the American Society for Virology July 18 2002 Lexington KY ."},{"issue":"10","key":"e_1_2_9_47_2","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/jvi.71.10.7758-7768.1997","article-title":"Evolution of the Sabin type 1 poliovirus in humans: Characterization of strains isolated from patients with vaccine\u2010associated paralytic poliomyelitis","volume":"71","author":"Georgescu M.\u2010M","year":"1997","journal-title":"Journal of Virology"},{"issue":"17","key":"e_1_2_9_48_2","first-page":"369","article-title":"Laboratory surveillance for wild poliovirus and vaccine\u2010derived poliovirus, 2000\u20132001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_9_49_2","unstructured":"Centers for Disease Control and Prevention. (2005).Poliovirus infections in four unvaccinated children\u2014Minnesota August\u2013October 2005.Morbidity and Mortality Weekly Report 54(Dispatch) 1\u20133."},{"key":"e_1_2_9_50_2","first-page":"181","article-title":"Molecular epidemiology of type 2 vaccine\u2010associated paralytic poliomyelitis in China","volume":"56","author":"Chiba Y.","year":"2003","journal-title":"Japanese Journal of Infectious Diseases"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13839-13847.2004"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.13.6791-6799.2002"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1633511100"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10224"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-5-1107"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0614"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.23.12460-12465.2003"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.08.011"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2005.05.027"},{"issue":"1","key":"e_1_2_9_60_2","first-page":"16","article-title":"Circulating vaccine\u2010derived polioviruses: Current state of knowledge","volume":"82","author":"Kew O. M.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"8","key":"e_1_2_9_61_2","first-page":"681","article-title":"Eradication of poliomyelitis in Cuba: A historical perspective","volume":"77","author":"M\u00e1s Lago P.","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117211"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg185"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.5.1029"},{"issue":"2","key":"e_1_2_9_65_2","first-page":"221","article-title":"Lesson from Cuba: Mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies","volume":"72","author":"M\u00e1s Lago P.","year":"1994","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.1.1"},{"issue":"1","key":"e_1_2_9_67_2","first-page":"s228\u2013s234","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine\u2010live attenuated oral poliovirus vaccine immunization schedules. Baltimore area polio vaccine study group","volume":"175","author":"Modlin J. F.","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"e_1_2_9_68_2","first-page":"265","article-title":"Comparison of the resistance of the intestinal tract to poliomyelitis virus (sabin's strains) in persons after naturally and experimentally acquired immunity","volume":"5","author":"Ghendon Y. Z.","year":"1961","journal-title":"Acta Virologica"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66386-6"},{"key":"e_1_2_9_70_2","unstructured":"UN Population Division. (2003).World Population Prospects Population Database: The 2002 Revision Population Database. Available athttp:\/\/esa.un.org\/unpp\/index.asp?panel=2 accessed July 31 2003."},{"issue":"1","key":"e_1_2_9_71_2","first-page":"3","article-title":"Search for polio virus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil and the United Kingdom","volume":"82","author":"Halsey N. A.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1086\/379791"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.11.011"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16150-3"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0003"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2893-2899.1998"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-1331-9"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.9.4876-4883.2004"},{"issue":"10","key":"e_1_2_9_79_2","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.38.10.3729-3734.2000","article-title":"Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel","volume":"38","author":"Shulman L. M.","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_9_80_2","unstructured":"Western Pacific Regional Office. (2005).Basic Health Information on Poliomyelitis(Revised as of 06 December 2005). Available athttp:\/\/www.wpro.who.int\/information_sources\/databases\/regional_statistics\/rstat_poliomyelitis.htm accessed January 19 2006."},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1105.0528"},{"key":"e_1_2_9_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.20.12623-12634.2005"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200306000-00019"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.67.785.301"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00443199"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1981.tb00095.x"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.09.005"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3001-3010.2000"},{"key":"e_1_2_9_89_2","unstructured":"MacCallum F. O.(1971).Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia.MedicalResearch Council Special Report Series 310 72\u201385."},{"key":"e_1_2_9_90_2","first-page":"75","article-title":"Characteristics of poliovirus strains from long\u2010term excretors with primary immunodeficiencies","volume":"105","author":"Minor P. D.","year":"2001","journal-title":"Developments in Biologicals"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.401"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-5773(05)80017-4"},{"key":"e_1_2_9_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009924"},{"issue":"1","key":"e_1_2_9_94_2","first-page":"S286\u2013 S292","article-title":"The biologic principles of poliovirus eradication","volume":"175","author":"Dowdle W. R.","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"e_1_2_9_95_2","first-page":"311","article-title":"Can post\u2010eradication laboratory containment of wild polioviruses be achieved?","volume":"80","author":"Dowdle W. R.","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_96_2","volume-title":"WHO Global Action Plan for Laboratory Containment of Wild Polioviruses","author":"World Health Organization","year":"2004"},{"key":"e_1_2_9_97_2","doi-asserted-by":"publisher","DOI":"10.1086\/514081"},{"key":"e_1_2_9_98_2","first-page":"217","article-title":"Detection of MEF\u20101 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande J. M.","year":"2003","journal-title":"Indian Journal of Medical Research"},{"issue":"1","key":"e_1_2_9_99_2","first-page":"59","article-title":"Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?","volume":"82","author":"Dowdle W. R.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_100_2","first-page":"625","volume-title":"Vaccines","author":"Plotkin S. A.","year":"2004"},{"issue":"6","key":"e_1_2_9_101_2","first-page":"145","article-title":"Resurgence of wild poliovirus type 1 transmission and consequences of importation\u201421 previously polio\u2010free countries, 2002\u20132005","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"1","key":"e_1_2_9_102_2","first-page":"24","article-title":"Certification of polio eradication: Process and lessons learned","volume":"82","author":"Smith J.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"e_1_2_9_103_2","first-page":"42","article-title":"Progress towards poliomyelitis eradication\u2013poliomyelitis outbreak in Sudan, 2004","volume":"80","author":"World Health Organization","year":"2005","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_2_9_104_2","unstructured":"Sutter R. W.(2002).Global burden estimate of vaccine\u2010associated paralytic poliomyelitis (VAPP). Presented at the WHO Informal Consultation on Research Towards Development of Post\u2010Certification Immunization Policy October 31\u2013November 1 2002. Geneva Switzerland ."},{"issue":"11","key":"e_1_2_9_105_2","first-page":"917","article-title":"Vaccine\u2010associated paralytic polio in India","volume":"80","author":"John T. J.","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/30.5.1034"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800058416"},{"key":"e_1_2_9_108_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195064650.001.0001","volume-title":"Experts in Uncertainty: Opinion and Subjective Probability in Science","author":"Cooke R. M.","year":"1991"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1080\/10807039609383660"},{"key":"e_1_2_9_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00843.x"},{"issue":"1","key":"e_1_2_9_111_2","first-page":"47","article-title":"Polio control after certification: Major issues outstanding","volume":"82","author":"Fine P. E. M.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"e_1_2_9_112_2","first-page":"9","article-title":"Cost analysis of post\u2010polio certification immunization policies","volume":"82","author":"Sangrujee N.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"e_1_2_9_113_2","first-page":"210","article-title":"Vaccine\u2010associated paralytic poliomyelitis in India during 1999: Decreased risk despite massive use of oral polio vaccine","volume":"80","author":"Kohler K. A.","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_114_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6845.79"},{"key":"e_1_2_9_115_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502233320804"},{"issue":"1","key":"e_1_2_9_116_2","first-page":"33","article-title":"Risk of vaccine\u2010associated paralytic poliomyelitis in Latin America, 1989\u201391","volume":"73","author":"Andrus J. K.","year":"1995","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_117_2","first-page":"739","article-title":"Safety of oral poliomyelitis vaccine: Results of a WHO enquiry","volume":"66","author":"Esteves K.","year":"1988","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"e_1_2_9_118_2","first-page":"53","article-title":"A developing country perspective on vaccine\u2010associated paralytic poliomyelitis","volume":"82","author":"John T. J.","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.5.926"},{"issue":"12","key":"e_1_2_9_120_2","first-page":"987","article-title":"Further clarity on vaccine\u2010associated paralytic polio in India (letter)","volume":"80","author":"Kohler K. A.","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_121_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199502000-00004"},{"key":"e_1_2_9_122_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"e_1_2_9_123_2","doi-asserted-by":"publisher","DOI":"10.1086\/498166"},{"key":"e_1_2_9_124_2","volume-title":"Transmissibility and Persistence of Oral Poliovirus Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative","author":"Fine P. E. M.","year":"1998"},{"key":"e_1_2_9_125_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S165"},{"key":"e_1_2_9_126_2","unstructured":"Equipe de dynamique des populations bact\u00e9riennes. (2004).Binomial Confidence Interval. Laboratoire de Biom\u00e9trie et Bioligie Evolutive Universit\u00e9 de Lyon . Available athttp:\/\/umr5558\u2010sud\u2010str3.univ\u2010lyon1.fr\u2010bici\u2010 accessed April 13 2004."},{"key":"e_1_2_9_127_2","volume-title":"Bayesian Data Analysis","author":"Gelman A. B.","year":"2000"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1539-6924.2006.00827.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1539-6924.2006.00827.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1539-6924.2006.00827.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1539-6924.2006.00827.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1539-6924.2006.00827.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T08:56:56Z","timestamp":1707382616000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1539-6924.2006.00827.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,15]]},"references-count":126,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1539-6924.2006.00827.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1539-6924.2006.00827.x","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,15]]}}}